Journal
ACTA NEUROPATHOLOGICA
Volume 120, Issue 2, Pages 261-267Publisher
SPRINGER
DOI: 10.1007/s00401-010-0701-2
Keywords
Gliomatosis cerebri; Diffuse infiltrative glioma; IDH1 mutation; Primary gliomatosis cerebri type 1; Primary gliomatosis cerebri type 2; Secondary gliomatosis cerebri
Categories
Funding
- Bundesministerium fur Bildung und Forschung (BMBF) [01GS0883, 01ES0729-30]
Ask authors/readers for more resources
The current WHO classification of brain tumors defines gliomatosis cerebri (GC) as an extensively infiltrating astrocytic glioma involving at least three cerebral lobes. The relation of GC to diffuse astrocytomas and glioblastoma is uncertain. Due to malignant biological behavior, GC is allotted to WHO grade III. Recent reports showed IDH1 mutations in astrocytic and oligodendroglial tumors WHO grades II and III and in secondary glioblastomas with a frequency of up to 90%, whereas IDH1 mutations occurred in only 5% of primary glioblastomas. Here, we examined the frequency of IDH1 mutations in 35 GC samples by direct sequencing, derived cleaved amplified polymorphic sequence analysis and immunohistochemistry. We identified IDH1 mutations in 10/24 (42%) cases, which also included a solid tumor portion (type 2 GC), but not in 11 classical cases without solid tumor mass (type 1 GC). TP53 mutations were revealed in two type 2 GC, but not in any type 1 GC, while combined chromosomal losses of 1p and 19q were not found at all. Our data suggest that GC consists of two histological/molecular subtypes, type 1 being clearly distinct from diffuse astrocytoma, and type 2 sharing features with diffuse astrocytoma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available